Intravenous Unfractionated Heparin Dosing for Suspected PE in Critically Ill Elderly Patient
For this 75-year-old patient with suspected PE in the setting of septic shock, AKI, metabolic acidosis, and respiratory failure requiring intubation, initiate IV unfractionated heparin with an 80 units/kg bolus followed by continuous infusion at 18 units/kg/hour, with subsequent dose adjustments based on aPTT monitoring using a standardized nomogram.
Rationale for Weight-Based Dosing Protocol
The FDA-approved dosing regimen and ESC guidelines both support weight-based heparin dosing over fixed-dose regimens 1, 2. The standard protocol consists of:
- Initial bolus: 80 units/kg IV push
- Continuous infusion: 18 units/kg/hour
- Target aPTT: 1.5-2.3 times control (46-70 seconds) 1
This approach achieves therapeutic anticoagulation more rapidly and reliably than fixed dosing, which is critical given the high mortality risk of untreated PE.
Critical Considerations in This Complex Patient
Septic Shock Context
Recent evidence suggests that therapeutic-dose IV heparin in septic shock may actually confer survival benefit, particularly in patients with higher severity of illness 3. In the highest APACHE II quartile, heparin was associated with a 30% relative reduction in 28-day mortality (HR 0.70, p=0.01). The presence of septic shock is not a contraindication to full-dose anticoagulation for PE—it may actually be beneficial 3.
Acute Kidney Injury Implications
While AKI complicates anticoagulation management, unfractionated heparin remains the preferred agent over LMWH in renal failure because it is not renally cleared and can be monitored with aPTT 1. The continuous IV infusion allows for immediate discontinuation if bleeding occurs, providing better control than subcutaneous alternatives.
Elderly Patient Adjustments
The FDA label notes that patients over 60 years may require lower heparin doses and have higher bleeding risk 2. However, do not empirically reduce the initial weight-based bolus and infusion rate. Instead:
- Start with standard weight-based dosing (80 units/kg bolus, 18 units/kg/hour)
- Monitor aPTT at 6 hours, then every 6 hours until stable
- Use the dose-adjustment nomogram more conservatively in this age group
- Consider checking aPTT more frequently (every 4-6 hours initially)
Dose Adjustment Protocol
Use this aPTT-based nomogram for all subsequent adjustments 1:
| aPTT Result | Action |
|---|---|
| <35 seconds (<1.2× control) | Give 80 units/kg bolus; increase infusion by 4 units/kg/hour |
| 35-45 seconds (1.2-1.5× control) | Give 40 units/kg bolus; increase infusion by 2 units/kg/hour |
| 46-70 seconds (1.5-2.3× control) | No change—therapeutic range |
| 71-90 seconds (2.3-3.0× control) | Reduce infusion by 2 units/kg/hour |
| >90 seconds (>3.0× control) | Stop infusion for 1 hour, then reduce by 3 units/kg/hour |
Critical Pitfalls to Avoid
Do not delay anticoagulation while awaiting definitive PE diagnosis in this hemodynamically unstable patient with high clinical suspicion 1. The mortality risk of untreated PE far exceeds bleeding risk in most scenarios.
Do not use fixed-dose protocols (e.g., 5,000 unit bolus, 1,000 units/hour) as these frequently result in subtherapeutic anticoagulation and delayed time to therapeutic range 2, 4.
Do not switch to LMWH in this patient with AKI and hemodynamic instability. Unfractionated heparin is superior because it allows immediate reversal with protamine if needed and doesn't accumulate in renal failure 1, 5.
Monitor for heparin-induced thrombocytopenia (HIT) starting day 4-5 of therapy, particularly given the septic shock context where platelet counts may fluctuate 2.
Monitoring Strategy
- aPTT: Check 6 hours after initiation, then every 6 hours until two consecutive therapeutic values, then daily
- Platelet count: Baseline, then every 2-3 days to screen for HIT
- Hemoglobin/hematocrit: Daily to detect occult bleeding
- Clinical bleeding assessment: Continuous monitoring for intracranial, GI, or pulmonary hemorrhage
Route of Administration Superiority
Use continuous IV infusion rather than subcutaneous administration in this critically ill patient 6. Recent data in septic patients demonstrated that IV infusion (500 units/hour) resulted in superior outcomes compared to subcutaneous dosing, with improved 14-day survival (p=0.008) 6. The continuous infusion provides more stable anticoagulation and allows immediate discontinuation if complications arise.